ArticleCancer diagnosis & prognosis

Recombinant Methioninase Lowers the Effective Dose of Regorafenib Against Colon-Cancer Cells: A Strategy for Widespread Clinical Use of a Toxic Drug.

Brad Barsam Choobin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.